Akiram Therapeutics AB
Pioneering targeted radioimmunotherapy to treat incurable solid tumors effectively.
Oversigt
- 1–4
- Medarbejdere
- 200–299t SEK
- Omsætning
- 2021
- Grundlagt
Nøglebeslutningstagere
Marika Nestor
Chief Executive Officer and Co-Founder
Anna Törner
Board Member
Peder Walberg
Board Member
Peter Frank
Chief Development Officer
+4 flere kontakter i Funnelfeedr
Beskrivelse
Akiram Therapeutics is an emerging Swedish biotechnology company dedicated to revolutionizing cancer treatment. They specialize in developing innovative, targeted radioimmunotherapy designed to treat solid tumors, particularly metastatic cancers. Their proprietary approach combines radioactive molec...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Tillverkning av läkemedel
- Juridisk form
- Aktiebolag
- Momsnummer
- SE559338745801
Beslutningstagere
8 kontakter i FunnelfeedrMarika Nestor
Chief Executive Officer and Co-Founder
Anna Törner
Board Member
Peder Walberg
Board Member
Peter Frank
Chief Development Officer
Fredrik Frejd
Chief Strategy Officer and Co-founder
Anja Mortensen
Chief Technology Officer and Co-founder
Tina Furebring
Project Management / Operations
Andre kontakter
Jan Zedenius
Clinical Advisor
Lignende virksomheder
20 lignende virksomheder i Funnelfeedr
Acrivon AB
10–19 medarbejdereDeveloping targeted cancer therapies using proprietary proteomics platform.
SACRA Therapeutics AB
0 medarbejdereSACRA pioneers novel RNA-targeting therapies for incurable cancers.
Affibody AB
50–99 medarbejdereDeveloping next-generation radiopharmaceuticals using proprietary Affibody technology.
AAX Biotech AB
5–9 medarbejdereResearch-driven biotech advancing antibody therapies via proprietary technology.
CANTARGIA AB
20–49 medarbejdereDeveloping antibody-based drugs targeting IL1RAP for serious diseases.
Udforsk mere
Spørgsmål om Akiram Therapeutics AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo